Repurposing Mitragynine As Anti-SARS-CoV-2 Agent Evidenced by In Silico Predictive Approach. Mal. J. Fund. Appl. Sci. 2022, 18 (6), 644-653. https://doi.org/10.11113/mjfas.v18n6.2637.